ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1206

$679K Total Retail Price of All Prescriptions

Rank: 55 out of 1206

587 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 16,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 967 902 1 2
SIMVASTATIN 789 696 2 1
OMEPRAZOLE 620 523 3 3
POTASSIUM CHLORIDE 619 558 4 12
LISINOPRIL 540 462 5 4
WARFARIN SODIUM 526 493 6 8
FUROSEMIDE 488 470 7 5
SERTRALINE HCL 461 442 8 22
HYDROCODONE-ACETAMINOPHEN 440 370 S3 9 7
HYDROCHLOROTHIAZIDE 393 373 10 11
RANITIDINE HCL 392 326 11 23
METOPROLOL TARTRATE 361 342 12 9
METFORMIN HCL 342 309 13 10
AMLODIPINE BESYLATE 312 278 14 6
ATORVASTATIN CALCIUM 274 252 15 13
METOPROLOL SUCCINATE 274 269 15 15
ALENDRONATE SODIUM 268 256 17 19
ATENOLOL 232 224 18 14
GLIMEPIRIDE 225 208 19 34
GABAPENTIN 217 168 20 18
LOSARTAN POTASSIUM 210 206 21 20
PRAVASTATIN SODIUM 207 185 22 21
PREDNISONE 191 188 23 28
AMITRIPTYLINE HCL 184 173 R 24 59
DOXAZOSIN MESYLATE 177 166 25 75
TAMSULOSIN HCL 174 153 26 26
ALLOPURINOL 173 171 27 24
TRAMADOL HCL 169 155 28 17
CLOPIDOGREL 161 152 29 48
AZITHROMYCIN 156 142 30 46
LOVASTATIN 151 148 31 44
CARVEDILOL 150 129 32 32
PANTOPRAZOLE SODIUM 148 127 33 54
GEMFIBROZIL 145 99 34 71
SPIRONOLACTONE 139 131 35 41
CITALOPRAM HBR 138 100 36 16
CARBIDOPA-LEVODOPA 138 124 36 70
DIOVAN 130 130 38 57
CYMBALTA 126 114 39 63
LANTUS 126 94 39 38
PLAVIX 122 111 41 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 68 42 27
OXYBUTYNIN CHLORIDE 114 91 43 68
FLUOXETINE HCL 113 100 44 52
CRESTOR 111 99 45 30
DIGOXIN 110 108 46 43
CIPROFLOXACIN HCL 99 83 47 61
FAMOTIDINE 97 68 48 65
CEFDINIR 94 78 49 161
BUMETANIDE 86 78 50 101
DOXYCYCLINE HYCLATE 85 66 51 103
TRIAMTERENE-HCTZ 82 71 52 33
CEPHALEXIN 80 74 53 62
FINASTERIDE 80 80 53 90
POLYETHYLENE GLYCOL 3350 79 38 55 31
FLUTICASONE PROPIONATE 77 59 56 42
MIRTAZAPINE 77 72 56 50
LOSARTAN-HYDROCHLOROTHIAZIDE 77 76 56 60
ADVAIR DISKUS 73 71 59 55
PROPRANOLOL HCL 70 46 60 92
ENALAPRIL MALEATE 68 68 61 45
MUPIROCIN 66 63 62 185
PAROXETINE HCL 64 58 63 53
ISOSORBIDE MONONITRATE ER 64 62 63 40
NEXIUM 63 57 65 47
ZOLPIDEM TARTRATE 62 61 66 25
BONIVA 61 52 67 226
DICLOFENAC SODIUM 61 56 67 104
VERAPAMIL ER 59 52 69 97
PREMARIN 59 56 R 69 147
SPIRIVA 58 43 71 66
NAMENDA 56 56 72 36
KLOR-CON 10 55 55 73 93
DETROL LA 54 54 74 125
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 74 76
VENLAFAXINE HCL 52 52 76 194
DILTIAZEM ER 52 52 76 83
DILTIAZEM 24HR CD 51 48 78 67
LEVOFLOXACIN 51 37 78 78
LIDODERM 50 31 80 199
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 40 80 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.